- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01117805
Women of Color and Asthma Control
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Research and practice efforts in asthma continue to overlook one of the most vulnerable subgroups of Americans, minority women. Women of color, especially African Americans, bear a significantly disproportionate burden of asthma among adults. However, no rigorous trial of an intervention to assist them with their particular challenges can be located. The proposed randomized controlled trial will evaluate an innovative intervention in 420 African American women with asthma. It will be the first to address both specific cultural factors affecting asthma and the influence of female sex and gender on control. It will use a highly tailored, telephone counseling approach designed to foster partnership with the clinician, resolution of specific asthma management problems, and identification of important contributing influences often misunderstood or ignored by women themselves as well as the health care system. It will attend closely to the role of allergy in asthma management as patients in the African American population have been shown to be at greater risk for allergic asthma.
Data will be collected at baseline, 12, and 24 months by telephone interview and from medical records. The hypotheses of the research are that women in the intervention group when compared to the control group will:
- Use emergency department services for asthma less frequently and need urgent care in a physician's office less often;
- Be hospitalized for asthma less frequently.
- Experience fewer symptoms of asthma;
- Have higher levels of asthma-related quality of life
The intervention aims to reduce the burden of asthma as carried by a large subgroup of the adult population. It employs state of the art asthma management strategies and creative means to reach and help patients at high risk of asthma exacerbations and health care use.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-2029
- University of Michigan School of Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The study participants will be a non-institutionalized ambulatory sample of women who are willing to participate in the project and meet the following criteria:
- Self-identify as African-American
- 18 years of age or older
- Are listed on the University of Michigan Health System (UMHS) Asthma Patient Registry, a validated, all-payer registry of patients with persistent asthma cared for within the UM Health System
- Have access to a telephone or cell phone
- Are not pregnant.. Because the UMHS Asthma Patient Registry is validated, there is minimal risk of diagnostic misclassification. The Registry is created and maintained with a two-step process of identification and validation. UMHS patients with persistent asthma are initially identified through the electronic medical record using National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) criteria, billing and claims data (when available), and then are validated using documented clinical diagnoses, pulmonary function test (PFT) results, or clinician review.
Exclusion Criteria:
- Patients with chronic respiratory conditions, including cystic fibrosis and chronic obstructive pulmonary disease (COPD) are excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intervention
Subjects will be randomized to the program intervention which is a female-specific, culturally relevant, self-regulation based telephone counseling intervention designed for African American women with asthma.
|
self-regulation telephone counseling program for African American women with asthma
Other Names:
|
|
No Intervention: usual care
Usual care at the University of Michigan Health System is based on the guidelines as recommended by the National Asthma Education and Prevention Program Expert Panel Report 3 (NAEPP-EPR3): Diagnosis and Treatment of Asthma and is coordinated so that all patients receive the same action plan, educational materials and instructions in use of devices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emergency department visits - 1st time point
Time Frame: 12months prior to baseline interview
|
We will collect health care utilization data related to asthma.
Women in the study will be asked during their baseline telephone interview to provide information regarding the frequency of Emergency Department visits related to asthma during the year prior to the baseline interview.
Second, women's CareWeb and billing records will be reviewed for asthma related ED visits during this time period.
|
12months prior to baseline interview
|
|
Emergency Department Visits -2nd time point
Time Frame: Interval between baseline interview and 12 month interview
|
We will collect health care utilization data related to asthma.
Women in the study will be asked during the SECOND TELEPHONE INTERVIEW to provide information regarding the frequency of Emergency Department visits related to asthma for their year between their baseline and 12month interview.
In addition, we will review their CareWeb and billing record data for that time period to see if there are any asthma related Emergency Department visits.
|
Interval between baseline interview and 12 month interview
|
|
Emergency Department Visits - 3rd time point
Time Frame: Interval between 12 month and 24 month telephone interview
|
We will collect health care utilization data related to asthma.
Women in the study will be asked during the THIRD TELEPHONE INTERVIEW to provide information regarding the frequency of Emergency Department visits related to asthma for their year between their 12 month and 24 month telephone interview.
In addition, we will review their CareWeb and billing record data for that time period to see if there are any asthma related Emergency Department visits.
|
Interval between 12 month and 24 month telephone interview
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospitalizations - first time point
Time Frame: Year prior to baseline interview
|
Women participating in the study will be asked during their BASELINE telephone interview to provide information on hospitalizations related to asthma for the year prior to their baseline interview.In addition, women's Careweb and billing records will be reviewed for hospitalizations for the above mentioned time period.
|
Year prior to baseline interview
|
|
Hospitalizations related to asthma - 2nd time point
Time Frame: interval between baseline and 12 month interview
|
Women participating in the study will be asked during each of their telephone interviews to provide information on hospitalizations related to asthma.
During their SECOND TELEPHONE INTERVIEW they will be asked to provide this information for the year between when their baseline interview was conducted and when we are administering the 12 month interview.
In addition, women's Careweb and billing records will be reviewed for hospitalizations for the above mentioned time period.
|
interval between baseline and 12 month interview
|
|
Hospitalizations related to asthma - 3rd time point
Time Frame: interval between 12month and 24 month telephone interview
|
Women participating in the study will be asked during each of their telephone interviews to provide information on hospitalizations related to asthma.
During their THIRD TELEPHONE INTERVIEW women will be asked to report the number of hospitalizations related to asthma that occurred for the year between when we conducted their 12 month interview and when we are administering the 24month interview.
In addition, women's Careweb and billing records will be reviewed for hospitalizations for the above mentioned time period.
|
interval between 12month and 24 month telephone interview
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Noreen M. Clark, PhD, University of Michigan School of Public Health
Publications and helpful links
General Publications
- Patel MR, Song PX, Sanders G, Nelson B, Kaltsas E, Thomas LJ, Janevic MR, Hafeez K, Wang W, Wilkin M, Johnson TR, Brown RW. A randomized clinical trial of a culturally responsive intervention for African American women with asthma. Ann Allergy Asthma Immunol. 2017 Feb;118(2):212-219. doi: 10.1016/j.anai.2016.11.016. Epub 2016 Dec 27.
- Janevic MR, Sanders GM, Thomas LJ, Williams DM, Nelson B, Gilchrist E, Johnson TR, Clark NM. Study protocol for Women of Color and Asthma Control: a randomized controlled trial of an asthma-management intervention for African American women. BMC Public Health. 2012 Jan 24;12:76. doi: 10.1186/1471-2458-12-76.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R18HL094272-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Meyer Children's Hospital IRCCSRecruitingAsthma in Children | Asthma Acute | Asthma Crisis | Asthma ChildhoodItaly
-
Tel-Aviv Sourasky Medical CenterThe Dalia and Eli Hurvitz Foundation GrantNot yet recruitingAsthma Attack | Asthma AcuteIsrael
-
University of PittsburghNational Institute of Environmental Health Sciences (NIEHS)RecruitingAsthma Exacerbation | Childhood Asthma | Air Pollution, Risk Reduction Behaviors | Asthma ControlUnited States
-
Vanderbilt University Medical CenterWithdrawnAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
Columbia UniversityChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingAcute Asthma | Pediatric Asthma | Non-invasive Positive Pressure Ventilation | BiPAPUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsRecruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicSingapore
-
Johann Wolfgang Goethe University HospitalCompleted
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingPersistent Asthma | Asthma (Diagnosis) | Moderate Asthma ExacerbationUnited States
Clinical Trials on Telephone counseling intervention
-
Aksaray UniversityCompletedType 2 Diabetes | Self-managementTurkey
-
Brown UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular DiseasesUnited States
-
Denver Health and Hospital AuthorityAmerican Diabetes AssociationCompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedObesity-Related Malignant NeoplasmUnited States
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Northwestern UniversityDiabetes Action Research and Education FoundationCompletedDiabetes Mellitus, Type 2 | Diabetes ComplicationsUnited States
-
National Institute of Diabetes and Digestive and...CompletedHypertension | Diabetes Mellitus, Type 2 | HyperlipidemiaUnited States
-
American Academy of Family PhysiciansRobert Wood Johnson Foundation; Agency for Healthcare Research and Quality...CompletedSmoking | Physical Activity | Diet | Alcohol AbuseUnited States
-
University of WashingtonU.S. Department of EducationCompletedBrain InjuriesUnited States